logo
Select company
Select metric
$ 612.95MShareholders Equity
VS
Market
59
Sector
81
Industry
90
History
17
$ 13.25Close
$ 5.57 - $ 16.36 52-Week Range
Ticker Information

Ticker

DNA

Company Name

GINKGO BIOWORKS HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSE

GINKGO BIOWORKS HOLDINGS INC - Shareholders Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DNA - Equity Historical data
DateShareholders Equity
6/30/2025$ 612.95M
3/31/2025$ 647.43M
12/31/2024$ 716.06M
9/30/2024$ 797.94M
6/30/2024$ 833.07M
3/31/2024$ 987.27M
12/31/2023$ 1.1B
9/30/2023$ 1.25B
6/30/2023$ 1.5B
3/31/2023$ 1.61B
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GINKGO BIOWORKS HOLDINGS INC's latest trailing twelve months (TTM) Equity stands at $ 20K.
  • Over the past 5 years, GINKGO BIOWORKS HOLDINGS INC's average Equity has been $ 1.06B.
  • The median Equity for GINKGO BIOWORKS HOLDINGS INC during this period was $ 1.1B
  • GINKGO BIOWORKS HOLDINGS INC reached its highest Equity over the past 5 years at $ 1.74B.
  • The lowest Equity recorded by GINKGO BIOWORKS HOLDINGS INC in the same timeframe $ 20K

GINKGO BIOWORKS HOLDINGS INC's Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Equity Benchmarks
CompanyEquity
AKBA : AKEBIA THERAPEUTICS INC $ 29.22MSTOK : STOKE THERAPEUTICS INC $ 334.94MIOVA : IOVANCE BIOTHERAPEUTICS INC $ 698.49MKROS : KEROS THERAPEUTICS INC $ 706.73MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ 460.83MGERN : GERON CORP $ 259.53MRCUS : ARCUS BIOSCIENCES INC $ 549MXERS : XERIS BIOPHARMA HOLDINGS INC $ -19.3MMRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ 265.86MCRMD : CORMEDIX INC $ 220.63M

Definition of Shareholders Equity

[Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.

DNA - Shareholders Equity, Last 5 years

$ 20K

Minimum

Dec 31, 2020

$ 1.74B

Maximum

Dec 31, 2022

$ 1.06B

Average

$ 1.1B

Median

Equity Benchmark Analysis

The chart above depicts the distribution of Equity for companies in the Total Stock Market. The average Equity of the companies is $ 384M with a standard deviation of $ 548.41M.
The following table provides additional summary stats:
Equity in the Market:
filtered constituents3.47K
min$ -1.4B
max$ 2.14B
average$ 384M
median$ 165.72M
std$ 548.41M